Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus.

Autor:	Hatano M; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Yajima N; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.; Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan.; Department of Clinical Epidemiology, Fukushima Medical University, Fukushima City, Japan.; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan., Yanai R; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Ishii S; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Tsujimoto Y; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.; Oku Medical Clinic, Osaka, Japan.; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto, Japan.; Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan., Azuma T; Department of General Medicine, Nara Prefecture General Medical Center, Nara, Japan., Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Japan., Kaneko Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Kameda H; Division of Rheumatology, Toho University, Tokyo, Japan., Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan., Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan., Nakagawa S; Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan., Nakajima A; Center for Rheumatic Diseases, Mie University Hospital, Mie, Japan., Hiramatsu Y; Department of Internal Medicine IV, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan., Fujita D; Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Miyamae T; Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan., Murashima A; Japan Drug Information Institute in Pregnancy National Center for Child Health and Development, Tokyo, Japan.
Jazyk:	angličtina
Zdroj:	Modern rheumatology [Mod Rheumatol] 2024 Oct 15; Vol. 34 (6), pp. 1170-1177.
DOI:	10.1093/mr/roae029
Abstrakt:	Objectives: A quality indicator (QI) for the treatment of systemic lupus erythematosus (SLE) during pregnancy and childbirth that is useful for sharing standard treatment policies has not yet been developed. This study aimed to develop a QI for SLE associated with pregnancy and childbirth. Methods: To identify candidate QIs, we conducted a systematic literature review on the development of QIs for SLE related to pregnancy and childbirth and on clinical practice guidelines. Candidate QI items were extracted from the final selected articles, and a first evaluation, panel meeting, and second evaluation were conducted to determine whether the candidate items were appropriate as QIs. Items for which all panel members reached a consensus were designated pregnancy and childbirth-related SLE QIs. Results: Four articles on SLE QI development and 28 practice guidelines were listed through abstract/text screening. Based on these studies, 52 candidate QIs were extracted that were limited to items related to pregnancy and childbirth and 41 items were selected on which all panel members agreed. Conclusion: We developed pregnancy-related SLE QIs using the RAND/UCLA method and selected 41 items, which could be used clinically. (© Japan College of Rheumatology 2024. Published by Oxford University Press.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu